UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): March 15, 2018
QUORUM HEALTH CORPORATION
(Exact name of registrant as specified in its charter)
Delaware |
| 001-37550 |
| 47-4725208 |
(State or other jurisdiction of incorporation) |
| (Commission |
| (IRS Employer Identification No.) |
|
|
|
|
|
1573 Mallory Lane Brentwood, Tennessee 37027
(Address of principal executive offices)
| ||||
Registrant’s Telephone Number, Including Area Code: (615) 221-1400
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
The information contained in this Current Report on Form 8-K (including the exhibits hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Item 2.02Results of Operations and Financial Condition
On March 15, 2018, Quorum Health Corporation (the “Company”) announced operating results for the fourth quarter and year ended December 31, 2017. A copy of the press release making this announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 2.02.
Item 7.01Regulation FD Disclosure
The press release referred to in Item 2.02 above also includes the Company’s 2018 annual earnings guidance. The 2018 guidance is based on the Company’s historical operating performance, current economic, demographic and regulatory trends and other assumptions the Company believes are reasonable at this time as set forth in the press release. A copy of the press release making this announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 7.01.
Item 9.01Financial Statements and Exhibits
(d)Exhibits
No. |
| Description |
|
|
|
99.1 |
| Quorum Health Corporation Press Release, dated March 15, 2018 |
1
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
QUORUM HEALTH CORPORATION (registrant) | ||
| ||
By: |
| /s/ Michael J. Culotta |
|
| Michael J. Culotta |
|
| Executive Vice President |
|
| and Chief Financial Officer |
|
| (principal financial officer and principal accounting officer) |
Date: March 15, 2018
2